August 11, 2025

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Growth Potential and Analyst Consensus Signal a Promising Future

iRhythm Technologies, Inc. (NASDAQ: IRTC), a prominent player in the healthcare sector, specifically within the medical devices industry, is attracting attention from investors for its innovative approach to cardiac monitoring...

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Unlocking a 23.58% Upside Potential with Solid Analyst Confidence

Bio-Rad Laboratories, Inc. (NYSE: BIO), a key player in the healthcare sector, is renowned for its advanced medical devices and diagnostics. With a market capitalization of $7.12 billion, the company..

Vaxcyte, Inc. (PCVX) Stock Analysis: A 284% Potential Upside Awaits Investors

Vaxcyte, Inc. (NASDAQ: PCVX), a biotechnology company dedicated to revolutionizing vaccine development, is capturing investor attention with its impressive potential upside of 284.20%. As the company advances its innovative pipeline,..

Madrigal Pharmaceuticals, Inc. (MDGL): Investor Outlook Reveals 26.81% Potential Upside

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is capturing attention in the biotechnology sector with its promising focus on developing treatments for metabolic dysfunction-associated steatohepatitis (MASH). Headquartered in West Conshohocken, Pennsylvania, Madrigal..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Unpacking the 48.20% Potential Upside in Genetic Medicine Innovations

Krystal Biotech, Inc. (NASDAQ: KRYS) is making waves in the biotechnology sector, standing out for its innovative approach to genetic medicines. With a market cap of $4.01 billion, this Pittsburgh-based..

TransMedics Group, Inc. (TMDX) Stock Analysis: Potential 24% Upside Amid Strong Revenue Growth

TransMedics Group, Inc. (NASDAQ: TMDX) is a pioneering force in the healthcare sector, specifically within the medical devices industry, with a focus on revolutionizing organ transplant therapy. Headquartered in Andover,..

Blueprint Medicines Corporation (BPMC) Stock Analysis: Navigating Growth in the Biotech Sector

Blueprint Medicines Corporation (NASDAQ: BPMC), a leading player in the biotechnology sector, continues to capture investor attention with its innovative approaches to treating genomically defined cancers and blood disorders. Headquartered..

Legend Biotech Corporation (LEGN) Stock Analysis: A Promising Biotech with a Potential Upside of 106%

Legend Biotech Corporation (NASDAQ: LEGN), a burgeoning force in the biotech sector, is catching the eye of investors with its robust growth potential and strategic focus on cutting-edge cell therapies...

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Evaluating a 24.85% Potential Upside Amidst Biotech Volatility

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a key player in the biotechnology sector, is at a pivotal point that presents a unique opportunity for investors. With its current market cap at..

BrightSpring Health Services (BTSG) Stock Analysis: Healthcare Innovator with 38% Upside Potential

BrightSpring Health Services, Inc. (BTSG) has captured the attention of investors with its robust growth prospects and a compelling potential upside of 38.15%. As a key player in the Healthcare..

Exact Sciences Corporation (EXAS) Stock Analysis: A 56% Potential Upside in the Healthcare Diagnostics Sector

Exact Sciences Corporation (NASDAQ: EXAS) stands as a prominent player in the healthcare sector, specifically in diagnostics and research. With a market capitalization of $7.76 billion, the company has carved..

Masimo Corporation (MASI): Investor Outlook on a 29.6% Potential Upside

Masimo Corporation (NASDAQ: MASI) stands out as a compelling investment opportunity in the healthcare sector, particularly in the medical devices industry. Headquartered in Irvine, California, Masimo specializes in innovative patient..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Biotech Gem with 42% Upside Potential

Soleno Therapeutics, Inc. (NASDAQ: SLNO) presents an intriguing opportunity for investors keen on the biotechnology sector, particularly those focused on companies developing treatments for rare diseases. With a market capitalization..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: A Biotech Pioneer with 101% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX), a prominent player in the biotechnology sector, continues to capture investor attention, not only due to its promising pipeline of radiopharmaceuticals but also because of..

Qiagen N.V. (QGEN) Stock Analysis: Navigating Potential 8.76% Upside in Diagnostics & Research

For individual investors keeping an eye on the healthcare sector, Qiagen N.V. (NYSE: QGEN) presents a compelling opportunity within the diagnostics and research industry. Based in Venlo, Netherlands, Qiagen has..

Neurocrine Biosciences (NBIX) Stock Analysis: A 34% Upside Potential in the Healthcare Sector

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) has captured the attention of investors with its robust performance in the healthcare sector, particularly in the field of neurological, neuroendocrine, and neuropsychiatric disorders. This..

Akero Therapeutics, Inc. (AKRO): Analyst Consensus Suggests 51% Upside Potential

Akero Therapeutics, Inc. (NASDAQ: AKRO) is capturing investor attention in the healthcare sector, with a market capitalization of $4.02 billion and a strong focus on biotechnology. The company is at..

HealthEquity, Inc. (HQY) Stock Analysis: A 31% Upside Potential for Investors

HealthEquity, Inc. (HQY), a prominent player in the Health Information Services industry, is making waves with its robust technology-enabled service platforms targeted at consumers and employers across the United States...

Bruker Corporation (BRKR): Investor Outlook on a Stock with 53.56% Potential Upside

Bruker Corporation (NASDAQ: BRKR) stands as a noteworthy player within the healthcare sector, specifically in the medical devices industry. With a market capitalization of $4.62 billion, this Massachusetts-based company is..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 73% Potential Upside

Lantheus Holdings, Inc. (NASDAQ: LNTH) is currently captivating the attention of investors with its robust portfolio in the healthcare sector, particularly in the drug manufacturing industry focusing on specialty and..

Search

Funds

August 11, 2025

Search

Funds

August 11, 2025

FTSE 100

Funds